Trials / Completed
CompletedNCT02218021
A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users
A Randomized, Double-Blind, Placebo- and Positive-Controlled, Crossover Study to Evaluate the Abuse Potential and Safety of Orally Administered Samidorphan in Non-Dependent Recreational Opioid Users
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Alkermes, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the abuse potential and safety of samidorphan in healthy, non-dependent, adult, recreational opioid users.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Samidorphan | |
| DRUG | Placebo | |
| DRUG | Oxycodone |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2014-08-15
- Last updated
- 2014-12-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02218021. Inclusion in this directory is not an endorsement.